Found 8 matching trials
Study of IV VTS-270 for Infantile Liver Disease Associated With Niemann-Pick Disease, Type C
PHASE1Niemann-Pick disease, type C (NPC) is a lethal, autosomal recessive, lysoso...
Location
St. Louis Children's Hospital
VTS-270 to Treat Niemann-Pick Type C1 (NPC1) Disease
PHASE2Due to different study designs, the sponsor separated Part C into a separat...
Location
University of Alabama at Birmingham
Niemann-Pick Type C Treatment With Adrabetadex for Symptoms of Brain and Nervous System
PHASE3This study was amended from expanded access to a clinical trial. Informatio...
Location
University of Arkansas System
Hydroxypropyl Beta Cyclodextrin for Niemann-Pick Type C1 Disease
PHASE1Background:
\- Hydroxypropyl beta cyclodextrin (HPBCD) is being tested for...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Open-label Study of VTS-270 in Participants With Neurologic Manifestations of Niemann-Pick Type C1
PHASE2This is a multicenter, multinational, open-label study of VTS-270 to evalua...
Location
Hospital Clinica Biblica
Adrabetadex to Treat Niemann-Pick Type C1 (NPC1) Disease
PHASE2Due to different study designs, the sponsor separated Part C into this sepa...
Location
University of Alabama at Birmingham
Combined Intrathecal and Intravenous VTS-270 Therapy for Liver and Neurological Disease Associated With Niemann-Pick Disease, Type C1
PHASE1Background:
For people who have Niemann-Pick disease, type C1 (NPC1), chol...
Location
National Institutes of Health Clinical Center
Safety and Tolerability Study of VTS-270 in Pediatric Participants With Niemann-Pick Type C (NPC) Disease
PHASE2This is a Phase-2, multicenter, multiple dose, open-label, 2-part evaluatio...
Location
Multiple Locations